Search research articles
Contact Us
Filters
Showing results (81-90 of 203) with videos related to
Page
of 21
Sort By:
Thrombosis Research
|
April 1, 1975
Heparin cofactor activity measured with an amidolytic method
O R Odegard, M Lie, U Abildgaard
Acta Medica Scandinavica
|
April 1, 1973
Changes in antithrombin 3 levels following cessation of anticoagulant therapy
O Refvem, M K Fagerhol, U Abildgaard
Lancet (London, England)
|
September 18, 1971
Antithrombin-3 concentration and ABO blood-groups
M K Fagerhol, U Abildgaard, L Kornstad
Thrombosis Research
|
March 1, 1976
Assay of heparin in plasma using a chromogenic substrate for activated factor X
A N Teien, M Lie, U Abildgaard
Thrombosis Research
|
August 15, 1987
A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions
P M Sandset, U Abildgaard, M Pettersen
Scandinavian Journal of Haematology
|
November 1, 1985
Changes in plasma antithrombin (heparin cofactor activity) during intravenous heparin therapy: observations in 198 patients with deep venous thrombosis
H A Holm, S Kalvenes, U Abildgaard
Journal of Internal Medicine
|
March 1, 1995
Long-term anticoagulant therapy in cerebrovascular disease: does bleeding outweigh the benefit?
T Dahl, U Abildgaard, P M Sandset
Folia Haematologica (Leipzig, Germany : 1928)
|
January 1, 1984
On the clinical significance of acquired antithrombin deficiency
Y Sørum, G F Handeland, U Abildgaard
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
November 27, 1998
[Venous thromboembolism--incidence and risk factors in Oslo]
F Strekerud, A M Johansen, U Abildgaard
Acta Paediatrica (Oslo, Norway : 1992)
|
August 1, 1995
Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis?
A Whitelaw, M C Mowinckel, U Abildgaard
Page
of 21
Search research articles
Search
Showing results (81-90 of 203) with videos related to
Sort By:
Page
of 21
Thrombosis Research
|
April 1, 1975
Heparin cofactor activity measured with an amidolytic method
O R Odegard, M Lie, U Abildgaard
Acta Medica Scandinavica
|
April 1, 1973
Changes in antithrombin 3 levels following cessation of anticoagulant therapy
O Refvem, M K Fagerhol, U Abildgaard
Lancet (London, England)
|
September 18, 1971
Antithrombin-3 concentration and ABO blood-groups
M K Fagerhol, U Abildgaard, L Kornstad
Thrombosis Research
|
March 1, 1976
Assay of heparin in plasma using a chromogenic substrate for activated factor X
A N Teien, M Lie, U Abildgaard
Thrombosis Research
|
August 15, 1987
A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions
P M Sandset, U Abildgaard, M Pettersen
Scandinavian Journal of Haematology
|
November 1, 1985
Changes in plasma antithrombin (heparin cofactor activity) during intravenous heparin therapy: observations in 198 patients with deep venous thrombosis
H A Holm, S Kalvenes, U Abildgaard
Journal of Internal Medicine
|
March 1, 1995
Long-term anticoagulant therapy in cerebrovascular disease: does bleeding outweigh the benefit?
T Dahl, U Abildgaard, P M Sandset
Folia Haematologica (Leipzig, Germany : 1928)
|
January 1, 1984
On the clinical significance of acquired antithrombin deficiency
Y Sørum, G F Handeland, U Abildgaard
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
November 27, 1998
[Venous thromboembolism--incidence and risk factors in Oslo]
F Strekerud, A M Johansen, U Abildgaard
Acta Paediatrica (Oslo, Norway : 1992)
|
August 1, 1995
Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis?
A Whitelaw, M C Mowinckel, U Abildgaard
Page
of 21